ESRX Insider Trading
ESRX | Market Equity
Comprehensive Trading Performance Summary
The investment history of corporate insiders at ESRX provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2018-11-10 00:02 | 2018-11-07 | MAC MAHON THOMAS P | Director | SELL | $99.50 | 5,234 | $520,793 | 0 | -100.0% |
| 2018-08-14 23:33 | 2018-08-10 | Houston Christine | Officer - Executive Vice President | OPT+S | $85.00 | 12,898 | $1,096,330 | 98,010 | 0.0% |
| 2018-06-15 23:14 | 2018-06-13 | Houston Christine | Officer - Executive Vice President | OPT+S | $82.28 | 10,000 | $822,800 | 98,010 | 0.0% |
| 2018-03-19 23:15 | 2018-03-15 | Houston Christine | Officer - Executive Vice President | OPT+S | $76.69 | 19,889 | $1,525,307 | 98,010 | 0.0% |
| 2018-03-03 00:40 | 2018-03-01 | Neville Everett | Officer - Exe VP, Strat, Sup Chn & Spclt | SELL | $75.26 | 4,895 | $368,398 | 11,176 | -30.5% |
| 2018-01-13 01:03 | 2018-01-11 | Stettin Glen D. | Officer - Sr. VP, Clin. Res. & New Sol. | SELL | $81.00 | 3,449 | $279,369 | 33,715 | -9.3% |
| 2018-01-05 00:06 | 2018-01-02 | Stettin Glen D. | Officer - Sr. VP, Clin. Res. & New Sol. | OPT+S | $76.00 | 3,448 | $262,048 | 37,055 | 0.0% |
| 2017-12-19 01:17 | 2017-12-15 | Houston Christine | Officer - Executive VP & COO | OPT+S | $70.08 | 10,104 | $708,048 | 77,296 | 0.0% |
| 2017-11-03 23:18 | 2017-11-01 | Anderson Phyllis S. | Officer - Sr. VP & Ch. Marketing Officer | SELL | $62.37 | 643 | $40,105 | 9,565 | -6.3% |
| 2017-11-01 00:13 | 2017-10-31 | WENTWORTH TIMOTHY C | Director, Officer - President & CEO | BUY | $61.13 | 8,000 | $489,002 | 106,628 | +8.1% |
| 2017-09-13 00:50 | 2017-09-11 | MYERS WOODROW A JR | Director | SELL | $63.93 | 3,900 | $249,343 | 11,500 | -25.3% |
| 2017-09-13 00:48 | 2017-09-08 | Anderson Phyllis S. | Officer - Sr. VP & Ch. Marketing Officer | SELL | $63.13 | 578 | $36,490 | 10,530 | -5.2% |
| 2017-08-25 23:05 | 2017-08-23 | Neville Everett | Officer - Sr. VP, Sup. Chain & Specialty | SELL | $61.48 | 1,163 | $71,501 | 18,232 | -6.0% |
| 2017-05-23 23:03 | 2017-05-19 | Anderson Phyllis S. | Officer - Sr. VP & Ch. Marketing Officer | SELL | $60.08 | 1,100 | $66,088 | 11,108 | -9.0% |
| 2017-03-03 00:29 | 2017-03-01 | Neville Everett | Officer - Sr VP-Supply Chain & Specialty | SELL | $70.16 | 2,352 | $165,016 | 8,935 | -20.8% |
| 2017-01-06 00:01 | 2017-01-03 | Neville Everett | Officer - Sr. VP, Sup. Chain & Specialty | SELL | $69.41 | 1,123 | $77,947 | 12,712 | -8.1% |
| 2016-11-15 00:02 | 2016-11-09 | Miller Steven B | Officer - Sr. VP & Chief Med. Officer | OPT+S | $75.02 | 21,798 | $1,635,351 | 34,817 | 0.0% |
| 2016-11-15 00:01 | 2016-11-09 | Anderson Phyllis S. | Officer - Sr. VP & Ch. Marketing Officer | SELL | $74.74 | 642 | $47,983 | 8,173 | -7.3% |
| 2016-09-16 23:47 | 2016-09-14 | MYERS WOODROW A JR | Director | OPT+S | $70.40 | 12,036 | $847,383 | 13,752 | 0.0% |
| 2016-09-13 23:51 | 2016-09-12 | McGinnis Christopher A | Officer - VP, Controller & Ch. Acct. Off | SELL | $70.77 | 1,785 | $126,324 | 3,170 | -36.0% |
| 2016-05-11 23:01 | 2016-05-10 | Neville Everett | Officer - Senior VP, Supply Chain | SELL | $74.11 | 800 | $59,288 | 13,835 | -5.5% |
| 2016-05-03 23:06 | 2016-04-29 | MAC MAHON THOMAS P | Director | OPT+S | $73.93 | 5,482 | $405,301 | 50,207 | 0.0% |
| 2016-03-12 00:27 | 2016-03-10 | McGinnis Christopher A | Officer - VP, Controller & Ch. Acct. Off | SELL | $68.56 | 579 | $39,695 | 5,929 | -8.9% |
| 2016-03-10 00:01 | 2016-03-07 | Anderson Phyllis S. | Officer - Sr. VP & Ch. Marketing Officer | SELL | $71.14 | 614 | $43,681 | 4,346 | -12.4% |
| 2016-03-04 00:03 | 2016-03-02 | STERNBERG SEYMOUR | Director | SELL | $71.47 | 8,400 | $600,349 | 31,062 | -21.3% |
| 2016-03-04 00:01 | 2016-03-01 | Houston Christine | Officer - Senior VP, Operations | OPT+S | $71.55 | 8,721 | $623,944 | 41,957 | 0.0% |
| 2016-03-02 01:49 | 2016-02-29 | Neville Everett | Officer - Senior VP, Supply Chain | SELL | $71.00 | 4,323 | $306,933 | 6,803 | -38.9% |
| 2015-06-11 22:29 | 2015-06-09 | Wimberly Gary | Officer - Sr. VP & Ch. Information Off. | SELL | $87.14 | 1,644 | $143,260 | 20,885 | -7.3% |
| 2015-06-03 23:01 | 2015-06-01 | Wimberly Gary | Officer - Sr. VP & Ch. Information Off. | OPT+S | $86.15 | 46,069 | $3,968,844 | 22,529 | 0.0% |
| 2015-05-29 23:02 | 2015-05-27 | STERNBERG SEYMOUR | Director | OPT+S | $90.23 | 6,870 | $619,859 | 4,397 | 0.0% |
| 2015-05-12 23:14 | 2015-05-08 | MYERS WOODROW A JR | Director | OPT+S | $85.32 | 14,342 | $1,223,645 | 12,378 | 0.0% |
| 2015-05-06 23:01 | 2015-05-04 | BENANAV GARY G | Director | OPT+S | $87.39 | 10,000 | $873,850 | 46,139 | 0.0% |
| 2015-05-05 23:09 | 2015-05-01 | Wade Sara E | Officer - Sr. VP, Ch. Human Res. Off. | SELL | $86.53 | 12,000 | $1,038,300 | 28,599 | -29.6% |
| 2015-05-05 23:07 | 2015-05-01 | Norton David A | Officer - SVP, Specialty & Supply Chain | OPT+S | $86.53 | 12,029 | $1,040,809 | 11,251 | 0.0% |
| 2015-03-04 00:15 | 2015-03-02 | Stettin Glen D. | Officer - Sr. VP, Clin. Res. & New Sol. | SELL | $84.39 | 2,674 | $225,659 | 8,291 | -24.4% |
| 2015-02-27 00:03 | 2015-02-24 | Stettin Glen D. | Officer - Sr. VP, Clin. Res. & New Sol. | OPT+S | $87.55 | 27,603 | $2,416,756 | 10,965 | 0.0% |
| 2014-12-04 00:07 | 2014-12-01 | Miller Steven B | Officer - Sr. VP & Chief Med. Officer | SELL | $83.57 | 4,896 | $409,144 | 16,521 | -22.9% |
| 2014-12-04 00:04 | 2014-12-02 | Ebling Keith J. | Officer - Exec. VP and General Counsel | SELL | $84.25 | 10,000 | $842,500 | 0 | -100.0% |
| 2014-12-02 00:03 | 2014-11-28 | Stettin Glen D. | Officer - Sr. VP, Clin. Res. & New Sol. | OPT+S | $82.96 | 10,800 | $895,946 | 19,857 | 0.0% |
| 2014-11-26 00:40 | 2014-11-21 | MAC MAHON THOMAS P | Director | OPT+S | $80.93 | 12,694 | $1,027,351 | 41,372 | 0.0% |
| 2014-11-26 00:38 | 2014-11-21 | Stettin Glen D. | Officer - Sr. VP, Clin. Res. & New Sol. | OPT+S | $81.50 | 10,874 | $886,231 | 19,857 | 0.0% |
| 2014-11-19 01:04 | 2014-11-17 | PARKER JOHN O | Director | OPT+S | $78.75 | 25,822 | $2,033,431 | 39,681 | 0.0% |
| 2014-11-11 00:16 | 2014-11-07 | Breen Maura C | Director | OPT+S | $77.80 | 13,128 | $1,021,345 | 17,310 | 0.0% |
| 2014-09-10 00:01 | 2014-09-05 | IGNACZAK EDWARD B | Officer - EVP | SELL | $75.28 | 9,886 | $744,216 | 75,996 | -11.5% |
| 2014-09-02 23:07 | 2014-08-28 | STERNBERG SEYMOUR | Director | OPT+S | $74.12 | 15,508 | $1,149,391 | 4,769 | 0.0% |
| 2014-08-26 23:04 | 2014-08-25 | Ebling Keith J. | Officer - Exec. VP and General Counsel | SELL | $75.50 | 10,000 | $755,000 | 10,000 | -50.0% |
| 2014-08-07 23:08 | 2014-08-05 | BENANAV GARY G | Director | OPT+S | $70.82 | 12,694 | $898,989 | 43,011 | 0.0% |
| 2014-08-06 23:13 | 2014-08-04 | Norton David A | Officer - Senior VP, Supply Chain | SELL | $71.02 | 1,276 | $90,627 | 0 | -100.0% |
| 2014-08-06 23:10 | 2014-08-05 | Wade Sara E | Officer - Sr. VP, Ch. Human Res. Off. | OPT+S | $70.44 | 20,000 | $1,408,800 | 29,532 | 0.0% |
| 2014-08-05 23:55 | 2014-08-01 | Breen Maura C | Director | OPT+S | $69.94 | 12,694 | $887,755 | 17,589 | 0.0% |
How to Interpret $ESRX Trades
Not every insider transaction in ESRX is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ESRX shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for ESRX
Insider activity data for ESRX is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ESRX, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.